Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NYSE:ABBV
AbbVie
|
161.28 | -20,61% | -10,12% | 284.799,16 | 3,86% | 7,03% |
|
NasdaqGS:AMGN
Amgen
|
308.45 | -11,11% | -2,21% | 165.463,28 | 2,9% | 5,31% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
67.54 | 21,22% | 30,5% | 84.144,93 | 4,67% | 0,15% |
|
NasdaqGM:ALXN
Alexion Pharmaceuticals
|
182.50 | 0% | 0% | 40.336,01 | 0% | 0% |
|
NasdaqGS:BIIB
Biogen
|
225.34 | -13,26% | 2,13% | 32.808,8 | 0% | -10,89% |
|
NasdaqGS:BMRN
BioMarin Pharmaceutical
|
80.50 | 142,2% | 221,62% | 15.385,96 | 0% | 32,46% |
|
NasdaqGS:INCY
Incyte
|
57.60 | 104,81% | 153,29% | 12.012,93 | 0% | 27,62% |
|
NasdaqCM:VKTX
Viking Therapeutics
|
72.35 | 0% | 0% | 8.843,51 | 0% | 0% |
|
NasdaqGS:BPMC
Blueprint Medicines
|
108.05 | 0% | 0% | 6.783,92 | 0% | 0% |
|
NasdaqGM:ARNA
Arena Pharmaceuticals
|
99.99 | 0% | 0% | 6.165,32 | 0% | 0% |
|
NasdaqGM:IOVA
Iovance Biotherapeutics
|
10.88 | 0% | 0% | 3.763,74 | 0% | 0% |
|
NasdaqGS:CCXI
ChemoCentryx
|
51.99 | 0% | 0% | 3.739,11 | 0% | 0% |
|
NasdaqGS:CBAY
CymaBay Therapeutics
|
32.44 | 0% | 0% | 3.724,47 | 0% | 0% |
|
NasdaqGM:DRNA
Dicerna Pharmaceuticals
|
38.01 | 0% | 0% | 2.986,1 | 0% | 0% |
|
NasdaqGM:FOLD
Amicus Therapeutics
|
9.04 | 0% | 0% | 2.807,75 | 0% | 0% |
|
NasdaqCM:CLDX
Celldex Therapeutics
|
40.11 | 0% | 0% | 2.631,15 | 0% | 0% |
|
NasdaqGS:ACAD
ACADIA Pharmaceuticals
|
15.18 | 0% | 0% | 2.512,75 | 0% | 0% |
|
NasdaqGM:VCEL
Vericel
|
48.52 | -94,78% | -76,15% | 2.364,47 | 0% | 0% |
|
NasdaqGM:ADMA
ADMA Biologics
|
8.79 | 0% | 0% | 2.042,24 | 0% | 0% |
|
NasdaqGM:ARDX
Ardelyx
|
8.02 | 0% | 0% | 2.040,28 | 0% | 0% |
